Michael Arzt, MD, investigated the use of ASV therapy in patients with TE-CSA and cardiovascular disease, finding it effective in reducing sleepiness and improving quality of life. It may be more ...
On May 15, 2015, Respironics, Inc., a Philips business, provided the following response to ResMed's Update on Phase IV SERVE-HF Study of Adaptive Servo-Ventilation (ASV) Therapy in Central Sleep Apnea ...
There's a problem though. CPAP doesn't seem to improve CVD-related outcomes. In some cases, it's even harmful. Let's do a quick review. In 2005, the CANPAP study found CPAP didn't improve a composite ...
Get all the latest news on coronavirus and more delivered daily to your inbox. Sign up here. As doctors face a shortage of ventilators that are crucial for treating coronavirus patients with ...
Overview Effect of Narcotics on Respiratory Physiology Treatment of Opioid-Induced Sleep-Disordered Breathing References Treatment of Opioid-Induced Sleep-Disordered Breathing The treatment of ...
The Food and Drug Administration (FDA) sent a warning notice to Philips Respironics after patients and medical suppliers claimed they were unaware that certain breathing assistance machines had been ...
Royal Philips ($PHG) said it is working with ResMed ($RMD) to analyze study data from mid-May showing that the latter company's Adaptive Servo-Ventilation (ASV ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback